Skip to content

Effects of sumac on inflammatory status, insulin resistance and antioxidant status in metabolic syndrome

The effect of Rhus Coriaria (Sumac) supplementation on inflammatory status, insulin resistance and antioxidant status in patients with metabolic syndrome: a randomized, triple-blind crossover clinical intervention

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200106046022N2
Enrollment
40
Registered
2021-07-22
Start date
2021-07-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. Metabolic syndrome

Interventions

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Adults 20-55 years old Metabolic syndrome based on modified ATPIII criteria

Exclusion criteria

Exclusion criteria: Having cardiovascular, liver, kidney, thyroid and diabetes diseases Pregnancy and lactation Follow a special diet Use of drugs that affect appetite, blood pressure, inflammation, fat metabolism and carbohydrates Use of multivitamin-mineral supplements, fatty acids and herbal remedies

Design outcomes

Primary

MeasureTime frame
Insulin resistance (Fasting blood sugar, Insulin, HOMA- IR?QUICKI). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.;Antioxidant status (MDA,CTL,SOD). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: En Existing commercial kits.;Inflammation status (CRP). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.

Secondary

MeasureTime frame
Waist Circumference. Timepoint: At the beginning and end of each intervention period. Method of measurement: Meters irreversible.;Weight. Timepoint: At the beginning and end of each intervention period. Method of measurement: Digital Balance.;BMI. Timepoint: At the beginning and end of each intervention period. Method of measurement: Divide the weight by the square of the height.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParvane Saneei

Esfahan University of Medical Sciences

saneeip@yahoo.com+98 31 3792 3159

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026